# OneBlood, Inc. – FDA Inspection, Mar 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/664cb338-476f-414a-a75b-878d38284d0b
Source feed: FDA_Inspections

> FDA inspection 1234432 of OneBlood, Inc., March 29, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234432
- Company Name: OneBlood, Inc.
- Inspection Date: 2024-03-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1106599 - 2019-09-24
- FDA Inspection 1028416 - 2017-05-24
- FDA Inspection 917322 - 2015-03-10
- FDA Inspection 828528 - 2013-04-23
- FDA Inspection 700895 - 2010-12-08

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laura-e-garcia/ad7c9bee-bbff-494f-b9cf-35c3a04316c0)

Company: https://www.keypedia.com/companies/oneblood-inc/10859614-5f9a-4175-9668-05b4d7de7784

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d